Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
BICYCLE THERAPEUTICS plc (BCYC)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/03/2023 |
8-K
| Quarterly results |
02/28/2023 |
8-K
| Quarterly results |
08/04/2022 |
8-K
| Quarterly results
Docs:
|
"Bicycle Therapeutics plc Condensed Consolidated Statements of Operations and Comprehensive Loss Three Months Ended Six Months Ended June 30, June 30, 2022 2021 2022 2021 Collaboration revenues $ 4,378 $ 1,785 $ 8,238 $ 3,593 Operating expenses: Research and development 19,854 11,722 34,138 21,415 General and administrative 11,824 7,340 28,783 15,479 Total operating expenses 31,678 19,062 62,921 36,894 Loss from operations Other income : Interest income 908 23 1,126 38 Interest expense Total other income , net 25 Net loss before income tax provision Benefit from income taxes Net loss $ $ $ $ Net loss per share, basic and diluted $ $ $ $ Weighted average ordinary shares outstanding, basic and diluted 29,648,564 24,052,168 29,626,974 23,047,745 Balance Sheets Data June 30, December..." |
|
05/05/2022 |
8-K
| Quarterly results |
03/01/2022 |
8-K
| Quarterly results |
11/04/2021 |
8-K
| Quarterly results |
08/05/2021 |
8-K
| Quarterly results |
05/06/2021 |
8-K
| Quarterly results |
03/11/2021 |
8-K
| Quarterly results |
11/05/2020 |
8-K
| Quarterly results |
08/05/2020 |
8-K
| Quarterly results |
05/07/2020 |
8-K
| Quarterly results |
03/10/2020 |
8-K
| Quarterly results |
11/07/2019 |
8-K
| Quarterly results |
08/08/2019 |
8-K
| Quarterly results |
|
|